-
Je něco špatně v tomto záznamu ?
Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2
P. Tagde, S. Tagde, P. Tagde, T. Bhattacharya, SM. Monzur, MH. Rahman, P. Otrisal, T. Behl, SS. Ul Hassan, MM. Abdel-Daim, L. Aleya, S. Bungau
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a deadly or devastating disease is known to affect thousands of people every day, many of them dying all over the planet. The main reason for the massive effect of COVID-19 on society is its unpredictable spread, which does not allow for proper planning or management of this disease. Antibiotics, antivirals, and other prescription drugs, necessary and used in therapy, obviously have side effects (minor or significant) on the affected person, there are still not clear enough studies to elucidate their combined effect in this specific treatment, and existing protocols are sometimes unclear and uncertain. In contrast, it has been found that nutraceuticals, supplements, and various herbs can be effective in reducing the chances of SARS-CoV-2 infection, but also in alleviating COVID-19 symptoms. However, not enough specific details are yet available, and precise scientific studies to validate the approved benefits of natural food additives, probiotics, herbs, and nutraceuticals will need to be standardized according to current regulations. These alternative treatments may not have a direct effect on the virus or reduce the risk of infection with it, but these products certainly stimulate the human immune system so that the body is better prepared to fight the disease. This paper aims at a specialized literary foray precisely in the field of these "cures" that can provide real revelations in the therapy of coronavirus infection.
Bhabha Pharmacy Research Institute Bhabha University Bhopal 462026 India
Chrono Environment CNRS 6249 Université de Franche Comté 25000 Besançon France
Department of Pharmacology Chitkara College of Pharmacy Chitkara University Punjab 140401 India
Department of Pharmacy Faculty of Medicine and Pharmacy University of Oradea 410028 Oradea Romania
Department of Pharmacy Jagannath University Sadarghat Dhaka 1100 Bangladesh
Department of Pharmacy Southeast University Banani Dhaka 1213 Bangladesh
Doctoral School of Biological and Biomedical Sciences University of Oradea 410087 Oradea Romania
Faculty of Physical Culture Palacký University Olomouc 77111 Olomouc Czech Republic
Integro Global Ltd Dhaka 1206 Bangladesh
Pharmacology Department Faculty of Veterinary Medicine Suez Canal University Ismailia 41522 Egypt
Practice of Medicine Department Government Homeopathic Medical College Bhopal 462003 India
PRISAL Foundation Pharmaceutical Royal International Society Bhopal 462042 India
School of Chemistry and Chemical Engineering Hubei University Hubei 430062 China
Techno India NJR Institute of Technology Udaipur 313003 India
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21023917
- 003
- CZ-PrNML
- 005
- 20211013134115.0
- 007
- ta
- 008
- 211006s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biomedicines9091266 $2 doi
- 035 __
- $a (PubMed)34572452
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Tagde, Priti $u Bhabha Pharmacy Research Institute, Bhabha University, Bhopal 462026, India $u PRISAL Foundation, Pharmaceutical Royal International Society, Bhopal 462042, India
- 245 10
- $a Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2 / $c P. Tagde, S. Tagde, P. Tagde, T. Bhattacharya, SM. Monzur, MH. Rahman, P. Otrisal, T. Behl, SS. Ul Hassan, MM. Abdel-Daim, L. Aleya, S. Bungau
- 520 9_
- $a The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a deadly or devastating disease is known to affect thousands of people every day, many of them dying all over the planet. The main reason for the massive effect of COVID-19 on society is its unpredictable spread, which does not allow for proper planning or management of this disease. Antibiotics, antivirals, and other prescription drugs, necessary and used in therapy, obviously have side effects (minor or significant) on the affected person, there are still not clear enough studies to elucidate their combined effect in this specific treatment, and existing protocols are sometimes unclear and uncertain. In contrast, it has been found that nutraceuticals, supplements, and various herbs can be effective in reducing the chances of SARS-CoV-2 infection, but also in alleviating COVID-19 symptoms. However, not enough specific details are yet available, and precise scientific studies to validate the approved benefits of natural food additives, probiotics, herbs, and nutraceuticals will need to be standardized according to current regulations. These alternative treatments may not have a direct effect on the virus or reduce the risk of infection with it, but these products certainly stimulate the human immune system so that the body is better prepared to fight the disease. This paper aims at a specialized literary foray precisely in the field of these "cures" that can provide real revelations in the therapy of coronavirus infection.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Tagde, Sandeep $u PRISAL Foundation, Pharmaceutical Royal International Society, Bhopal 462042, India
- 700 1_
- $a Tagde, Pooja $u Practice of Medicine Department, Government Homeopathic Medical College, Bhopal 462003, India
- 700 1_
- $a Bhattacharya, Tanima $u School of Chemistry and Chemical Engineering, Hubei University, Hubei 430062, China $u Techno India NJR Institute of Technology, Udaipur 313003, India
- 700 1_
- $a Monzur, Shams Minhaz $u Integro Global Ltd., Dhaka 1206, Bangladesh
- 700 1_
- $a Rahman, Md Habibur $u Department of Pharmacy, Jagannath University, Sadarghat, Dhaka 1100, Bangladesh $u Department of Pharmacy, Southeast University, Banani, Dhaka 1213, Bangladesh
- 700 1_
- $a Otrisal, Pavel $u Faculty of Physical Culture, Palacký University Olomouc, 77111 Olomouc, Czech Republic
- 700 1_
- $a Behl, Tapan $u Department of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India
- 700 1_
- $a Ul Hassan, Syed Shams $u Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China $u Department of Natural Product Chemistry, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
- 700 1_
- $a Abdel-Daim, Mohamed M $u Department of Pharmaceutical Sciences, Batterjee Medical College, P.O. Box 6231, Jedah 21442, Saudi Arabia $u Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt
- 700 1_
- $a Aleya, Lotfi $u Chrono-Environment CNRS 6249, Université de Franche-Comté, 25000 Besançon, France
- 700 1_
- $a Bungau, Simona $u Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania $u Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania
- 773 0_
- $w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 9, č. 9 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34572452 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20211006 $b ABA008
- 991 __
- $a 20211013134112 $b ABA008
- 999 __
- $a ind $b bmc $g 1708131 $s 1144411
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 9 $c 9 $e 20210918 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
- LZP __
- $a Pubmed-20211006